Literature DB >> 15615794

The severe cardiorenal syndrome: 'Guyton revisited'.

Lennart G Bongartz1, Maarten Jan Cramer, Pieter A Doevendans, Jaap A Joles, Branko Braam.   

Abstract

The incidence of cardiac failure and chronic renal failure is increasing and it has now become clear that the co-existence of the two problems has an extremely bad prognosis. We propose the severe cardiorenal syndrome (SCRS), a pathophysiological condition in which combined cardiac and renal dysfunction amplifies progression of failure of the individual organ, so that cardiovascular morbidity and mortality in this patient group is at least an order of magnitude higher than in the general population. Guyton has provided an excellent framework describing the physiological relationships between cardiac output, extracellular fluid volume control, and blood pressure. While this model is also sufficient to understand systemic haemodynamics in combined cardiac and renal failure, not all aspects of the observed accelerated atherosclerosis, structural myocardial changes, and further decline of renal function can be explained. Since increased activity of the renin-angiotensin system, oxidative stress, inflammation, and increased activity of the sympathetic nervous system seem to be cornerstones of the pathophysiology in combined chronic renal disease and heart failure, we have explored the potential interactions between these cardiorenal connectors. As such, the cardiorenal connection is an interactive network with positive feedback loops, which, in our view, forms the basis for the SCRS.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15615794     DOI: 10.1093/eurheartj/ehi020

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  130 in total

Review 1.  Nonthyroidal illness and the cardiorenal syndrome.

Authors:  Christiaan L Meuwese; Olaf M Dekkers; Peter Stenvinkel; Friedo W Dekker; Juan J Carrero
Journal:  Nat Rev Nephrol       Date:  2013-09-03       Impact factor: 28.314

2.  Peritoneal dialysis reduces the number of hospitalization days in heart failure patients refractory to diuretics.

Authors:  Cécile Courivaud; Amir Kazory; Thomas Crépin; Raymond Azar; Catherine Bresson-Vautrin; Jean-Marc Chalopin; Didier Ducloux
Journal:  Perit Dial Int       Date:  2013-09-01       Impact factor: 1.756

Review 3.  Ultrafiltration in decompensated heart failure.

Authors:  Brian E Jaski; David Miller
Journal:  Curr Heart Fail Rep       Date:  2005-09

4.  Initiation and Cessation Timing of Renal Replacement Therapy in Patients with Type 1 Cardiorenal Syndrome: An Observational Study.

Authors:  Buyun Wu; Wenyan Yan; Xing Li; Xiangqing Kong; Xiangbao Yu; Yamei Zhu; Changying Xing; Huijuan Mao
Journal:  Cardiorenal Med       Date:  2017-01-20       Impact factor: 2.041

5.  Angiotensin II receptor blocker irbesartan attenuates cardiac dysfunction induced by myocardial infarction in the presence of renal failure.

Authors:  Ryo Watanabe; Jun-Ichi Suzuki; Kouji Wakayama; Hidetoshi Kumagai; Yuichi Ikeda; Hiroshi Akazawa; Issei Komuro; Mitsuaki Isobe
Journal:  Hypertens Res       Date:  2015-12-10       Impact factor: 3.872

Review 6.  Managing acute renal failure in patients with acute decompensated heart failure: the cardiorenal syndrome.

Authors:  Ravi V Shah; Michael M Givertz
Journal:  Curr Heart Fail Rep       Date:  2009-09

Review 7.  Epidemiology, pathophysiology, clinical characteristics and management of childhood cardiorenal syndrome.

Authors:  Wasiu A Olowu
Journal:  World J Nephrol       Date:  2012-02-06

Review 8.  The genetics of congestive heart failure.

Authors:  Calum A MacRae
Journal:  Heart Fail Clin       Date:  2010-04       Impact factor: 3.179

9.  Loss-of-function DNA sequence variant in the CLCNKA chloride channel implicates the cardio-renal axis in interindividual heart failure risk variation.

Authors:  Thomas P Cappola; Scot J Matkovich; Wei Wang; Derek van Booven; Mingyao Li; Xuexia Wang; Liming Qu; Nancy K Sweitzer; James C Fang; Muredach P Reilly; Hakon Hakonarson; Jeanne M Nerbonne; Gerald W Dorn
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-19       Impact factor: 11.205

10.  Relation between dose of loop diuretics and outcomes in a heart failure population: results of the ESCAPE trial.

Authors:  Vic Hasselblad; Wendy Gattis Stough; Monica R Shah; Yuliya Lokhnygina; Christopher M O'Connor; Robert M Califf; Kirkwood F Adams
Journal:  Eur J Heart Fail       Date:  2007-08-24       Impact factor: 15.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.